A 60-year-old man with a history of cerebral infarction presented at our hospital. He was subsequently diagnosed to have multiple liver metastases of advanced descending colon cancer, based on the findings of computed tomography. His physical examination showed hemiplegia of the right upper and lower limbs. He was treated with palliative chemotherapy, consisting of capecitabine, oxaliplatin (XELOX), and bevasizumab. After two cycles of this chemotherapy, handfoot syndrome (HFS) prominently developed in the palm of his left hand (Picture 1). HFS remained for seven days after the onset of symptoms (Picture 2). HFS is the most common toxicity of capecitabine related to the tissue-specific expression of drug-metabolizing enzymes and it is usually seen in both the hands and the feet (1). To our knowledge, this is only the second case of capecitabine-induced unilateral HFS to be reported (2). This report suggests that HFS is strongly linked to the mechanical disturbance of daily life and it may also influence the onset of long-term paralysis. 
